electroCore, Inc.

electroCore is a bioelectronic medicine company specializing in non-invasive vagus nerve stimulation (nVNS) technology. The company develops and commercializes proprietary nVNS devices designed to treat various neurological and immunological disorders. Their flagship product, gammaCore, is a wearable nVNS device that stimulates the vagus nerve to deliver therapeutic benefits for conditions including migraine, cluster headache, PTSD, and mild traumatic brain injury. The company has published clinical evidence in peer-reviewed journals demonstrating the efficacy of nVNS therapy across multiple indications. electroCore positions itself as a pioneer in bioelectronic medicine, leveraging vagus nerve stimulation as a drug-free, non-invasive therapeutic approach. The company is publicly traded on NASDAQ and actively pursues investigator-led clinical trials to expand the therapeutic applications of their nVNS platform. Their products are designed for patient self-administration and home use, making them accessible to broader patient populations.